Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Florian Röhrig"'
Autor:
Matthias Kroiss, Axel Walch, Sabine Kendl, Florian Röhrig, Laura-Sophie Landwehr, José Pedro Friedmann Angeli, Na Sun, Jochen Schreiner, Martin Fassnacht, Katja Kiseljak-Vassiliades, Margaret E. Wierman, Isabel Weigand, Hanna Urlaub, Silviu Sbiera
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 3, Pp 1-12 (2020)
Cell Death and Disease, Vol 11, Iss 3, Pp 1-12 (2020)
Conditions of impaired adrenal function and tissue destruction, such as in Addison’s disease, and treatment resistance of adrenocortical carcinoma (ACC) necessitate improved understanding of the pathophysiology of adrenal cell death. Due to relevan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433f8b4bf37057839e44e778b75d42dc
https://doi.org/10.1038/s41419-020-2385-4
https://doi.org/10.1038/s41419-020-2385-4
Autor:
Florian Röhrig, Jochen Schreiner, Sabine Kendl, Martin Fassnacht, Kerstin Höfner, Katja Kiseljak-Vassiliades, Isabel Weigand, Matthias Kroiss, Silviu Sbiera
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::021c973e392eba28d948adfc634d674a
https://doi.org/10.1530/endoabs.63.gp100
https://doi.org/10.1530/endoabs.63.gp100
Autor:
Almut Schulze, Florian Röhrig
Publikováno v:
Nature Reviews Cancer. 16:732-749
Lipid metabolism, in particular the synthesis of fatty acids (FAs), is an essential cellular process that converts nutrients into metabolic intermediates for membrane biosynthesis, energy storage and the generation of signalling molecules. This Revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6757dc1aca20dcfbcf4ff2032c612f96
https://doi.org/10.1038/nrc.2016.89
https://doi.org/10.1038/nrc.2016.89
Autor:
Friedrich Schütze, Sandra Vorlová, Süleyman Ergün, Sabine Gätzner, Erik Henke, Florian Röhrig, Anja E Kuhn
Publikováno v:
Scientific Reports
Tumors are characterized by a rigid, highly cross-linked extracellular matrix (ECM), which impedes homogeneous drug distribution and potentially protects malignant cells from exposure to therapeutics. Lysyl oxidases are major contributors to tissue s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac91c8f8af04c87a6df9c8e4cb05f3e5
http://europepmc.org/articles/PMC4665164
http://europepmc.org/articles/PMC4665164
Autor:
Andreas Rosenwald, Sandra Vorlová, Florian Röhrig, Erik Henke, David A. Scheinberg, H. Hoffmann, Sabine Gätzner, Isabel Weigand, Zvi Granot, Martin Wartenberg, Olaf Penack, Freddy E. Escorcia, Süleyman Ergün, S Keller, M Tenspolde, Katia Manova
Publikováno v:
Oncogene
Röhrig, F; Vorlová, S; Hoffmann, H; Wartenberg, Martin; Escorcia, F E; Keller, S; Tenspolde, M; Weigand, I; Gätzner, S; Manova, K; Penack, O; Scheinberg, D A; Rosenwald, A; Ergün, S; Granot, Z; Henke, E (2016). VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene, 36(1), pp. 1-12. Nature Publishing Group 10.1038/onc.2016.182
Röhrig, F; Vorlová, S; Hoffmann, H; Wartenberg, Martin; Escorcia, F E; Keller, S; Tenspolde, M; Weigand, I; Gätzner, S; Manova, K; Penack, O; Scheinberg, D A; Rosenwald, A; Ergün, S; Granot, Z; Henke, E (2016). VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene, 36(1), pp. 1-12. Nature Publishing Group 10.1038/onc.2016.182
The inadequate transport of drugs into the tumor tissue caused by its abnormal vasculature is a major obstacle to the treatment of cancer. Anti-vascular endothelial growth factor (anti-VEGF) drugs can cause phenotypic alteration and maturation of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8777a0ad8aeebff2ef297f59590917
https://pubmed.ncbi.nlm.nih.gov/27270432
https://pubmed.ncbi.nlm.nih.gov/27270432